United States · 
Who invested in Nested Therapeutics?
Nested Therapeutics's investors include Goldman Sachs, Versant Ventures, Foresite Capital, S32 and Goldman Sachs Assetmanagement.
United States · Series A startup
Who invested in Nested Therapeutics
Funding summaryUpdated 26 Oct 2026
$90Mraised across 1 round since 2022, from 1 source
- Latest round
- Series A, $90MOct 2022
- Investors
- 5
The rounds
- Oct 2022Series A$90M
Source recorded
Founders and team
From Nested Therapeutics's own website: 9 on the team.
- Darrin MilesChief Executive Officer
- Ann Marie KennedyVice President, Clinical Operations
- Beth GunningVice President, Finance and Operations
- Philip KomarnitskyChief Medical Officer
- Tanja WeberChief Business Officer
- John A. OrwinChairman of the Board
- John ClarkClinical Trial Manager
- Steve IadarolaDirector, Information Technology
- Tom FrohlichIndependent Director
Everyone who backed them
Goldman Sachs AssetmanagementVC firm1round
Missing a round, or an investor who was in one? Tell us.
Quick answers about Nested Therapeutics
How much has Nested Therapeutics raised?
Nested Therapeutics has raised $90M across 1 round since 2022.
When did Nested Therapeutics last raise?
Nested Therapeutics's most recent round was a Series A of $90M in Oct 2022.
What was Nested Therapeutics's biggest round?
Its most recent round, $90M in Oct 2022, is also its largest on record.
Who backed Nested Therapeutics first?
Nested Therapeutics's first round on record, in Oct 2022, was backed by Goldman Sachs, Versant Ventures and Foresite Capital and 2 others.
What stage is Nested Therapeutics at?
Nested Therapeutics's latest named round is a Series A, in Oct 2022.
Where is Nested Therapeutics based?
Nested Therapeutics is based in the United States.
Companies like Nested Therapeutics
In the same sector, and raised in the last eighteen months.
Find investors like these
Search every investor by what they have actually funded, then narrow to your stage and market. Free.